Prolactinoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Prolactinoma}} | {{Prolactinoma}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
Prolactinoma may be classified based on either size or location. Based on size, a prolactinoma can be classified as a 'microprolactinoma'' (<10 mm diameter) or ''macroprolactinoma'' (>10 mm diameter). | |||
Based on size, a prolactinoma can be classified as a 'microprolactinoma'' (<10 mm diameter) or ''macroprolactinoma'' (>10 mm diameter). | |||
==Classification== | ==Classification== | ||
Prolactinoma may be classified based on either size or location. | Prolactinoma may be classified based on either size or location. | ||
===Based on size=== | ===Based on size=== | ||
A prolactinoma can be classified as | A prolactinoma can be classified as | ||
*''microprolactinoma'' (<10 mm diameter) | *''microprolactinoma'' (<10 mm diameter) | ||
*''macroprolactinoma'' (>10 mm diameter) | *''macroprolactinoma'' (>10 mm diameter) | ||
===Based on location=== | ===Based on location=== | ||
The classification for pituitary adenomas is as follows: | The classification for pituitary adenomas is as follows: | ||
*0: Normal [[pituitary]] appearance. | *0: Normal [[pituitary]] appearance. | ||
*I: Enclosed within the sella turcica, microadenoma, smaller than 10 mm | *I: Enclosed within the sella turcica, microadenoma, smaller than 10 mm | ||
*II: Enclosed within the [[sella turcica]], macroadenoma, 10 mm or larger | *II: Enclosed within the [[sella turcica]], macroadenoma, 10 mm or larger | ||
*III: Invasive, locally, into the sella | *III: Invasive, locally, into the sella | ||
*IV: Invasive, diffusely, into the sella | *IV: Invasive, diffusely, into the sella | ||
The grading schema for suprasellar extensions is as follows: | The grading schema for suprasellar extensions is as follows: | ||
*A: 0 to 10 mm suprasellar extension occupying the suprasellar cistern | *A: 0 to 10 mm suprasellar extension occupying the suprasellar cistern | ||
*B: 10 mm to 20 mm extension and elevation of the third [[ventricle]] | *B: 10 mm to 20 mm extension and elevation of the third [[ventricle]] | ||
*C: 20 mm to 30 mm extension occupying the anterior of the third ventricle | *C: 20 mm to 30 mm extension occupying the anterior of the third ventricle | ||
*D: A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions<ref>http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_3</ref><ref>Yeh PJ, Chen JW: Pituitary tumors: surgical and medical management. Surg Oncol 6 (2): 67-92, 1997. [PUBMED Abstract]</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref> | *D: A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions<ref>http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_3</ref><ref>Yeh PJ, Chen JW: Pituitary tumors: surgical and medical management. Surg Oncol 6 (2): 67-92, 1997. [PUBMED Abstract]</ref><ref>Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98</ref> | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Revision as of 18:23, 6 September 2015
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma classification On the Web |
|
American Roentgen Ray Society Images of Prolactinoma classification |
|
Risk calculators and risk factors for Prolactinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Prolactinoma may be classified based on either size or location. Based on size, a prolactinoma can be classified as a 'microprolactinoma (<10 mm diameter) or macroprolactinoma (>10 mm diameter).
Classification
Prolactinoma may be classified based on either size or location.
Based on size
A prolactinoma can be classified as
- microprolactinoma (<10 mm diameter)
- macroprolactinoma (>10 mm diameter)
Based on location
The classification for pituitary adenomas is as follows:
- 0: Normal pituitary appearance.
- I: Enclosed within the sella turcica, microadenoma, smaller than 10 mm
- II: Enclosed within the sella turcica, macroadenoma, 10 mm or larger
- III: Invasive, locally, into the sella
- IV: Invasive, diffusely, into the sella
The grading schema for suprasellar extensions is as follows:
- A: 0 to 10 mm suprasellar extension occupying the suprasellar cistern
- B: 10 mm to 20 mm extension and elevation of the third ventricle
- C: 20 mm to 30 mm extension occupying the anterior of the third ventricle
- D: A larger than 30 mm extension, beyond the foramen of Monro, or Grade C with lateral extensions[1][2][3]
References
- ↑ http://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq#section/_3
- ↑ Yeh PJ, Chen JW: Pituitary tumors: surgical and medical management. Surg Oncol 6 (2): 67-92, 1997. [PUBMED Abstract]
- ↑ Hardy J: Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds.: Diagnosis and treatment of pituitary tumors: proceedings of a conference sponsored jointly by the National Institute of Child Health and Human Development and the National Cancer Institute, January 15-17, 1973, Bethesda, Md. Amsterdam, The Netherlands: Excerpta medica, 1973, pp 179-98